All In MedTech

Device Trial Radar · NCT04812444

Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion

Safety and Efficacy of Peripheral Venous Stent System in the Treatment of Patients With Iliac Vein Stenosis or Occlusion: a Prospective, Multicentre, Randomized Controlled Clinical Trial.

Last checked: Nov 20, 2026Latest source record: Oct 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 220 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

220

Actual

Start

Oct 9, 2020

Primary completion

Oct 20, 2023

Study completion Oct 20, 2023

Sponsor

Lead sponsor
Zhejiang Zylox Medical Device Co., Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Mar 23, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Clinical study on safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusion.

Conditions

  • Iliac Vein Stenosis
  • Iliac Vein Occlusion

Interventions

  • Zylox Peripheral Venous StentDevice

    Self-expanding stent implantation during the index procedure.

  • Zilver Vena Venous StentDevice

    Self-expanding stent implantation during the index procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target vascular patency rate at 12 months after operationTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.